Would You Like To Book A SmartState Program Speaker?

Click Here

Dr. Richard Drake

Endowed Chair in Proteomics


  • Expert in the proteomics analysis of clinical tissue and fluid samples related to prostate, kidney, colon, and breast cancers.
  • Director, MUSC Proteomics Center, one of the most advanced mass spectrometry resources in South Carolina.
  • Extensive translational center research experience and involvement in sample biorepositories.
  • Economic development emphasis on generating biomedical-related biomarker tests for cancer, neurological and metabolic diseases.
  • Fellowship, Biochemistry & Molecular Biology, University of Texas Health Science Center
  • PhD, University of Kentucky

Dr. Richard Drake’s research in proteomics focuses on identifying specific protein biomarkers associated with different types and stages of cancers, as well as developing protein biomarker tests that could monitor the effectiveness of treatment. Ultimately, the Proteomics Center of Economic Excellence hopes to translate the research of Dr. Drake and his team into commercialized biomarker tests for a variety of medical fields. 

Dr. Drake is among the nation’s leading experts on the complex role of proteins in the development of cancer. In addition to his SmartState Endowed Chair appointment, he is a professor in the MUSC Department of Cell and Molecular Pharmacology and Experimental Therapeutics, and is working with scientists at MUSC’s Hollings Cancer Center. 

Dr. Drake has significant funding from the National Institutes of Health and Department of Defense for prostate and kidney cancer research. His research could result in commercialized biomarker tests for a variety of medical fields, including new diagnostic tests that define how well cancer treatments are working.

Connect With SmartState Endowed Chairs To Learn About Their Research And Business Development Opportunities

Click Here